Quimigen Portugal > IRAK2 Antibody - C-terminal region - HRP
IRAK2 Antibody - C-terminal region - HRP
Referencia ARP61222_P050-HRP
embalaje : 100ul
Marca : Aviva Systems Biology
IRAK2 Antibody - C-terminal region : HRP (ARP61222_P050-HRP)
| Datasheets/Manuals | Printable datasheet for anti-IRAK2 (ARP61222_P050-HRP) antibody |
|---|
| Predicted Species Reactivity | Human, Mouse, Rat, Cow, Guinea Pig, Horse, Rabbit, Yeast |
|---|---|
| Product Format | Liquid. Purified antibody is supplied in high phosphate PBS, 100 mm phosphate, 150 mM NaCl, pH 7.6. |
| Clonality | Polyclonal |
| Host | Rabbit |
| Conjugation | HRP: Horseradish Peroxidase |
| Application | WB |
| Reconstitution and Storage | All conjugated antibodies should be stored in light-protected vials or covered with a light protecting material (i.e. aluminum foil). Conjugated antibodies are stable for at least 12 months at 4C. If longer storage is desired (24 months), conjugates may be diluted with up to 50% glycerol and stored at -20C to -80C. Freezing and thawing conjugated antibodies will compromise enzyme activity as well as antibody binding. |
| Immunogen | The immunogen is a synthetic peptide directed towards the C terminal region of human IRAK2 |
| Purification | Affinity Purified |
| Predicted Homology Based on Immunogen Sequence | Cow: 93%; Guinea Pig: 93%; Horse: 79%; Human: 100%; Mouse: 79%; Rabbit: 79%; Rat: 86%; Yeast: 83% |
| Peptide Sequence | Synthetic peptide located within the following region: SSSEACVGLEPPQDVTETSWQIEINEAKRKLMENILLYKEEKVDSIELFG |
| Concentration | 0.5 mg/ml |
| Blocking Peptide | For anti-IRAK2 (ARP61222_P050-HRP) antibody is Catalog # AAP61222 (Previous Catalog # AAPP47368) |
| Gene Symbol | IRAK2 |
|---|---|
| Gene Full Name | Interleukin-1 receptor-associated kinase 2 |
| Alias Symbols | IRAK-2 |
| NCBI Gene Id | 3656 |
| Protein Name | Interleukin-1 receptor-associated kinase-like 2 |
| Description of Target | IRAK2 encodes the interleukin-1 receptor-associated kinase 2, one of two putative serine/threonine kinases that become associated with the interleukin-1 receptor (IL1R) upon stimulation. IRAK2 is reported to participate in the IL1-induced upregulation of NF-kappaB. |
| Uniprot ID | O43187 |
| Protein Accession # | NP_001561 |
| Nucleotide Accession # | NM_001570 |
| Protein Size (# AA) | 625 |
| Molecular Weight | 69kDa |
| Protein Interactions | TNFSF9; TRAF6; HSP90AA1; PSEN1; IRAK1; IL1R1; MYD88; UBC; TIRAP; SESTD1; ZC3H12C; ZC3H12A; FASTKD5; ADCK3; YTHDF1; TOLLIP; IRAK4; TARDBP; SARM1; SNRNP200; IRAK3; CDC37; IQSEC1; IQCB1; BAG3; STT3A; ARAF; TNFAIP3; MME; TICAM2; SMURF1; IRAK2; TLR4; SMAD2; HR |
Protein interactions
| Name | # of Products |
|---|---|
| ADCK3 | 6 |
| ARAF | 77 |
| BAG3 | 45 |
| CDC37 | 169 |
| FASTKD5 | 5 |
| HRAS | 211 |
| IL1R1 | 45 |
| IQCB1 | 6 |
| IQSEC1 | 14 |
| IRAK1 | 192 |
| IRAK2 | 89 |
| IRAK3 | 21 |
| IRAK4 | 46 |
| MME | 191 |
| MYD88 | 146 |
| PELI1 | 16 |
| PELI2 | 25 |
| PELI3 | 13 |
| SARM1 | 23 |
| SESTD1 | 3 |
| SMAD2 | 408 |
| SMURF1 | 189 |
| SNRNP200 | 24 |
| STT3A | 10 |
| TARDBP | 19 |
| TICAM2 | 57 |
| TIRAP | 122 |
| TLR3 | 76 |
| TLR4 | 158 |
| TNFAIP3 | 141 |
| TOLLIP | 123 |
| TRAF6 | 443 |
| UBC | 7030 |
| YTHDF1 | 7 |
| ZC3H12A | 16 |
| ZC3H12C | 3 |
Biological pathways
| Name | # of Products |
|---|---|
| Activation of MAPK activity | 317 |
| I-kappaB kinase/NF-kappaB cascade | 54 |
| Inflammatory response | 911 |
| Innate immune response | 905 |
| Interleukin-1-mediated signaling pathway | 31 |
| JNK cascade | 79 |
| MyD88-dependent toll-like receptor signaling pathway | 331 |
| MyD88-independent toll-like receptor signaling pathway | 288 |
| Negative regulation of NF-kappaB transcription factor activity | 94 |
| Nucleotide-binding oligomerization domain containing signaling pathway | 60 |
| Positive regulation of NF-kappaB transcription factor activity | 346 |
| Regulation of cytokine-mediated signaling pathway | 17 |
| Stress-activated MAPK cascade | 207 |
| Toll signaling pathway | 369 |
| Toll-like receptor 1 signaling pathway | 309 |
| Toll-like receptor 2 signaling pathway | 309 |
| Toll-like receptor 3 signaling pathway | 272 |
| Toll-like receptor 4 signaling pathway | 330 |
Biological process
| Name | # of Products |
|---|---|
| Activation of MAPK activity | 105 |
| I-kappaB kinase/NF-kappaB cascade | 37 |
| Inflammatory response | 339 |
| Innate immune response | 300 |
| Interleukin-1-mediated signaling pathway | 19 |
| JNK cascade | 53 |
| Lipopolysaccharide-mediated signaling pathway | 48 |
| MyD88-dependent toll-like receptor signaling pathway | 65 |
| MyD88-independent toll-like receptor signaling pathway | 56 |
| Negative regulation of NF-kappaB transcription factor activity | 49 |
| Nucleotide-binding domain, leucine rich repeat containing receptor signaling pathway | 36 |
| Nucleotide-binding oligomerization domain containing signaling pathway | 20 |
| Positive regulation of NF-kappaB transcription factor activity | 135 |
| Protein phosphorylation | 451 |
| Regulation of cytokine-mediated signaling pathway | 4 |
| Response to interleukin-1 | 34 |
| Signal transduction | 1058 |
| Stress-activated MAPK cascade | 47 |
| Toll signaling pathway | 66 |
| Toll-like receptor 1 signaling pathway | 59 |
| Toll-like receptor 2 signaling pathway | 61 |
| Toll-like receptor 3 signaling pathway | 54 |
| Toll-like receptor 4 signaling pathway | 64 |
| Toll-like receptor signaling pathway | 71 |
| TRIF-dependent toll-like receptor signaling pathway | 53 |
Cellular components
| Name | # of Products |
|---|---|
| Cell surface | 369 |
| Cytosol | 1868 |
| Endosome membrane | 110 |
| Plasma membrane | 2678 |
Protein function
| Name | # of Products |
|---|---|
| ATP binding | 2814 |
| Nucleotide binding | 3928 |
| Protein binding | 12191 |
| Protein heterodimerization activity | 1132 |
| Protein homodimerization activity | 1852 |
| Protein kinase activity | 636 |
| Transferase activity, transferring phosphorus-containing groups | 127 |
-
IRAK2 ELISA Kit (Human) (OKCD01275)Catalog #: OKCD01275Application: ELISA-SandwichKit Range: 0.78-50ng/mLSensitivity: < 0.27 ng/mL


